Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69801 - 69825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CCND2	894	upregulated	Silicon Dioxide analog results in increased expression of CCND2 mRNA	12p13.32	A24194
Silicon dioxide	Approved	CCND3	896	downregulated	Silicon Dioxide analog results in decreased expression of CCND3 mRNA	6p21.1	A24195
Silicon dioxide	Approved	CCNE1	898	upregulated	Silicon Dioxide results in increased expression of CCNE1 mRNA	19q12	A24196
Silicon dioxide	Approved	CCNF	899	upregulated	Silicon Dioxide analog results in increased expression of CCNF mRNA	16p13.3	A24195
Silicon dioxide	Approved	CCNG2	901	downregulated	Silicon Dioxide analog results in decreased expression of CCNG2 mRNA	4q21.1	A24195
Silicon dioxide	Approved	CCNL1	57018	upregulated	Silicon Dioxide results in increased expression of CCNL1 mRNA	3q25.31	A24196
Silicon dioxide	Approved	CCNO	10309	upregulated	Silicon Dioxide analog results in increased expression of CCNO mRNA	5q11.2	A24195
Silicon dioxide	Approved	CCPG1	9236	downregulated	Silicon Dioxide analog results in decreased expression of CCPG1 mRNA	15q21.3	A24195
Silicon dioxide	Approved	CCPG1	9236	downregulated	Silicon Dioxide results in decreased expression of CCPG1 mRNA	15q21.3	A24196
Silicon dioxide	Approved	CCR1	1230	downregulated	Silicon Dioxide analog results in decreased expression of CCR1 mRNA	3p21.31	A24194
Silicon dioxide	Approved	CCR2	729230	upregulated	Silicon Dioxide results in increased expression of CCR2 mRNA	3p21.31	A24204
Silicon dioxide	Approved	CCR6	1235	downregulated	Silicon Dioxide results in decreased expression of CCR6 mRNA	6q27	A24203
Silicon dioxide	Approved	CCR7	1236	downregulated	Silicon Dioxide analog results in decreased expression of CCR7 mRNA	17q21.2	A24195
Silicon dioxide	Approved	CCR7	1236	downregulated	Silicon Dioxide results in decreased expression of CCR7 mRNA	17q21.2	A24203
Silicon dioxide	Approved	CCR8	1237	downregulated	Silicon Dioxide results in decreased expression of CCR8 mRNA	3p22.1	A24203
Silicon dioxide	Approved	CCT6B	10693	downregulated	Silicon Dioxide analog results in decreased expression of CCT6B mRNA	17q12	A24195
Silicon dioxide	Approved	CCT6B	10693	downregulated	Silicon Dioxide results in decreased expression of CCT6B mRNA	17q12	A24196
Silicon dioxide	Approved	CD14	929	downregulated	Silicon Dioxide results in decreased expression of CD14 mRNA	5q31.3	A24196
Silicon dioxide	Approved	CD163L1	283316	upregulated	Silicon Dioxide analog results in increased expression of CD163L1 mRNA	12p13.31	A24195
Silicon dioxide	Approved	CD19	930	downregulated	Silicon Dioxide analog results in decreased expression of CD19 mRNA	16p11.2	A24195
Silicon dioxide	Approved	CD1D	912	upregulated	Silicon Dioxide analog results in increased expression of CD1D mRNA	1q23.1	A24194
Silicon dioxide	Approved	CD22	933	upregulated	Silicon Dioxide analog results in increased expression of CD22 mRNA	19q13.12	A24195
Silicon dioxide	Approved	CD274	29126	upregulated	Silicon Dioxide analog results in increased expression of CD274 mRNA	9p24.1	A24195
Silicon dioxide	Approved	CD2BP2	10421	upregulated	Silicon Dioxide results in increased expression of CD2BP2 mRNA	16p11.2	A24196
Silicon dioxide	Approved	CD300LG	146894	upregulated	Silicon Dioxide analog results in increased expression of CD300LG mRNA	17q21.31	A24195

Displaying entries 69801 - 69825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability